‘Practice-changing’ research shows adding immunotherapy before and after surgery reduced recurrences for early-stage gastric cancer.

by Laura Gesualdi Gilmore

Forward Look

Breast surgeon Maria Margarete Karsten discusses how using patient-reported outcomes can improve quality of life.

by Ashley P. Taylor

Forward Look

Researchers explore adding immunotherapy before surgery to help improve outcomes for people with locally advanced disease.

by Risa Kerslake

Forward Look

When exposed to a near-infrared laser, injected microparticles release heat and chemotherapy directly to the tumor.

by Leah Lawrence

Researchers explore the potential of immune checkpoint inhibitors before surgery to prevent recurrence in several cancers.

by Kendall K. Morgan

PSMA-targeted therapy, which delivers radiation directly to cancer cells, provides a new approach for those whose prostate cancer stops responding to other treatments.

by Stephen Ornes

Healthy Habits

Adding calcium-rich foods to your diet may reduce colorectal cancer risk.

by Anne Danahy

Facts and Stats

As people live longer and treatment improves, the population of cancer survivors continues to grow.

by Thomas Celona

Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.

by Kyle Bagenstose

Immunotherapies, cancer vaccines and more from Cancer Today’s coverage of the AACR Annual Meeting 2025.